Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria

NCT00935389 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Lupus Nephritis
Proteinuria
CTX

Interventions

DRUG: tripterygium glycosides

Sponsor

Nanjing University School of Medicine